TY  - GEN 
AU  - Rueda Etxebarria, Jon
AU  - Miguel Beriain, Íñigo de
AU  - Montoliu, Lluis
PY  - 2024
UR  - https://hdl.handle.net/10481/96154
AB  - Casgevy, the world’s first approved CRISPR-based cell therapy, has been priced at $2.2 million per patient.
Although this hefty price tag was widely anticipated, the extremely high cost of this and other cell and gene
therapies poses a major ethical...
LA  - eng
KW  - Genetic Justice
KW  - CRISPR Ethics
KW  - Global Health
KW  - Rare Diseases
KW  - Casgevy
TI  - Affordable pricing of CRISPR treatments is a pressing ethical imperative
DO  - https://doi.org/10.1089/crispr.2024.0042
ER  -